Lys170
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.7.5
Powered by Cell Signaling Technology
Home > Ubiquitylation Site Page: > Lys170  -  SIRT6 (human)

Site Information
GRLCTVAkARGLRAC   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 40212801

In vivo Characterization
Methods used to characterize site in vivo:
mass spectrometry ( 1 , 3 ) , mass spectrometry (in vitro) ( 2 ) , mutation of modification site ( 2 )
Relevant cell line - cell type - tissue:

Downstream Regulation
Effects of modification on SIRT6:
protein stabilization ( 2 )
Effects of modification on biological processes:
DNA repair, induced ( 2 ) , transcription, inhibited ( 2 )

References 

1

Akimov V, et al. (2018) UbiSite approach for comprehensive mapping of lysine and N-terminal ubiquitination sites. Nat Struct Mol Biol 25, 631-640
29967540   Curated Info

2

Ronnebaum SM, Wu Y, McDonough H, Patterson C (2013) The ubiquitin ligase CHIP prevents SirT6 degradation through noncanonical ubiquitination. Mol Cell Biol 33, 4461-72
24043303   Curated Info

3

Udeshi ND, et al. (2013) Refined preparation and use of anti-diglycine remnant (K-ε-GG) antibody enables routine quantification of 10,000s of ubiquitination sites in single proteomics experiments. Mol Cell Proteomics 12, 825-31
23266961   Curated Info